Metastatic melanoma with heterologous bone after neoadjuvant immunotherapy: diagnostic insights
{{output}}
We report a BRAF V600E-mutated cutaneous melanoma (pT3b) with nodal metastases treated with neoadjuvant anti-PD-1 therapy. Axillary lymph node dissection demonstrated residual viable melanoma intimately associated with extensive heterologous lamellar bone form... ...
